ACE and COVID-19: Based on these findings, the counterbalance between ACE and ACE2 activities in COVID-19 may play a crucial role in the thrombo-inflammatory processes described in severe pneumonia with evolution in ARDS, and the D/D genotype of ACE could also be a part of this crucial pathophysiological aspect [7,8,9,10,11].